These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1391966)

  • 21. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prophylaxis of hepatic veno-occlusive disease by low-molecular-weight heparin and lipo- prostaglandin E1 after allogeneic peripheral blood stem cell transplantation].
    Song CY; Li YH; Guo KY; Wu BY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 May; 23(5):494, 497. PubMed ID: 12754143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation.
    Dowlati A; Honore P; Damas P; Deprez M; Delwaide J; Fillet G; Beguin Y
    Transplantation; 1995 Jul; 60(1):106-9. PubMed ID: 7624933
    [No Abstract]   [Full Text] [Related]  

  • 24. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
    Sullivan KM; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak MF; Davis C; Appelbaum FR; Buckner CD; Hansen JA; Shulman HM; Storb R; McDonald GB
    Biol Blood Marrow Transplant; 1998; 4(1):20-6. PubMed ID: 9701388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.
    Salat C; Holler E; Hiller E; Pihusch R; Kolb HJ
    Haematologica; 1999 Jun; 84 Suppl EHA-4():40-3. PubMed ID: 10907464
    [No Abstract]   [Full Text] [Related]  

  • 26. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
    Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
    Blood; 1998 Dec; 92(12):4568-72. PubMed ID: 9845522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation.
    Rosti G; Bandini G; Belardinelli A; Calori E; Tura S; Gherlinzoni F; Miggiano C
    Lancet; 1992 Jun; 339(8807):1481-2. PubMed ID: 1351153
    [No Abstract]   [Full Text] [Related]  

  • 28. Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation.
    Laporte JP; Lesage S; Tilleul P; Najman A; Gorin NC
    Lancet; 1992 Apr; 339(8800):1057. PubMed ID: 1349081
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1.
    Ibrahim A; Pico JL; Maraninchi D; Zambon E; Attal M; Brault P; Tilly H; Blaise D; Hayat M
    Bone Marrow Transplant; 1991; 7 Suppl 2():53. PubMed ID: 1878718
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytokines in veno-occlusive disease of the liver after bone marrow transplantation.
    Remberger M; Ringdén O
    Transplant Proc; 1995 Dec; 27(6):3533-4. PubMed ID: 8540087
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment with recombinant soluble thrombomodulin of two cases of sinusoidal obstructive syndrome/hepatic veno-occlusive disease after bone marrow transplantation.
    Ohwada C; Takeuchi M; Kawaguchi T; Tsukamoto S; Sakai S; Takeda Y; Abe D; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C
    Am J Hematol; 2011 Oct; 86(10):886-8. PubMed ID: 21818767
    [No Abstract]   [Full Text] [Related]  

  • 32. [Low dose heparin for the prevention of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation].
    Chen J; Zhu KE; Zhang T; Zhong J; Chen ST; Zeng HL
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):140-2. PubMed ID: 17445443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic veno-occlusive disease following bone marrow transplantation.
    Grandt NC
    Oncol Nurs Forum; 1989; 16(6):813-7. PubMed ID: 2687804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation.
    Gluckman E; Jolivet I; Scrobohaci ML; Devergie A; Traineau R; Bourdeau-Esperou H; Lehn P; Faure P; Drouet L
    Br J Haematol; 1990 Mar; 74(3):277-81. PubMed ID: 2159315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of vitamin E and glutamine in the successful treatment of severe veno-occlusive disease following bone marrow transplantation.
    Nattakom TV; Charlton A; Wilmore DW
    Nutr Clin Pract; 1995 Feb; 10(1):16-8. PubMed ID: 7898412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.
    Essell JH; Schroeder MT; Harman GS; Halvorson R; Lew V; Callander N; Snyder M; Lewis SK; Allerton JP; Thompson JM
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):975-81. PubMed ID: 9625683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High plasma levels of tumor necrosis factor-alpha may be predictive of veno-occlusive disease in bone marrow transplantation.
    Gugliotta L; Catani L; Vianelli N; Gherlinzoni F; Miggiano MC; Bandini G; Tura S
    Blood; 1994 Apr; 83(8):2385-6. PubMed ID: 8161809
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation.
    Fried MW; Duncan A; Soroka S; Connaghan DG; Farrand A; Peter J; Strauss RM; Boyer TD; McDonald GB
    Bone Marrow Transplant; 2001 Mar; 27(6):635-9. PubMed ID: 11319594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
    Park SH; Lee MH; Lee H; Kim HS; Kim K; Kim WS; Jung CW; Im YH; Yoon SS; Kang WK; Park K; Park CH; Kim SW
    Bone Marrow Transplant; 2002 Jan; 29(2):137-43. PubMed ID: 11850708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteplase for hepatic veno-occlusive disease after bone marrow transplantation.
    Ringdén O; Wennberg L; Ericzon BG; Kallman R; Aström M; Duraj F; Söderdahl G; Tydén G; Groth CG
    Lancet; 1992 Aug; 340(8818):546-7. PubMed ID: 1354293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.